![](/img/cover-not-exists.png)
The anti-CD20 antibody Rituximab reduces the Th17 response
Frank L. van de Veerdonk, Bernard Lauwerys, Franco DiPadova, Renoud J. Marijnissen, Marije I. Koenders, Ilse Gutierrez-Roelens, Patrick Durez, Mihai G. Netea, Jos W.M. van der Meer, Wim B. van den BerVolume:
48
Year:
2009
Language:
english
DOI:
10.1016/j.cyto.2009.07.412
File:
PDF, 44 KB
english, 2009